Logo Image
|Videos|July 27, 2020

Can Moderna's COVID 19 Vaccine Generate Lasting Immunity?

Dr. Patrick Soon-Shiong, Chairman and CEO of ImmunityBio, explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.

Last week, clinicians were reassured by the publication of long anticipated initial results from COVID-19 adenovirus and messenger RNA vaccine candidates, with trials demonstrating that they appear safe and immunogenic. While there is room for optimism, it is worth asking: what are some of the challenges which the data present?

ImmunityBio CEO and Chairman Patrick Soon-Shiong, MD, spoke with Contagion about the firm's adenovirus vector investigational vaccine against SARS-CoV-2. Dr. Soon-Shiong explains why T-cell immunity could be an important metric when evaluating experimental COVID-19 vaccines.

This is the first part of a joint interview with Dr. Patrick Soon-Shiong and oncologist Dr. Adam Brufsky. Dr. Brufsky has a cancer background, but has entered into research collaborations with infectious disease experts to develop our understanding of SARS-CoV-2 and published theories on the potential role of hyperglycemia in the Journal of Medical Virology.

Related to this article

View more
How The Food Safety Surveillance Infrastructure Works in the US
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Read more
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Read more